UNITED THERAPEUTICS CORP (UTHR)

ROTHBLATT MARTINE A 🟡 adjusted position in 9.5K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $571.66 ($8.1M) Transaction Date: May 08, 2026 | Filing ID: 000050

Register to leave comments

  • News bot May 11, 2026, 8:31 p.m.

    🔍 ROTHBLATT MARTINE A (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2026-05-08

    Transaction Summary:

    • Total transactions: 17
    • Derivative instruments: 1
    • Holdings reported: 5
    • Total shares acquired: 9,500
    • Total shares sold: 19,000
    • Total shares held: 639,284

    Detailed Transactions and Holdings:

    • Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
      Date: 2026-05-08 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,126 shares of Common Stock at $562.083 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 48,887.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,022 shares of Common Stock at $563.0571 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 46,865.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,864 shares of Common Stock at $564.002 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 45,001.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 1,983 shares of Common Stock at $564.7694 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 43,018.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 705 shares of Common Stock at $565.9862 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 42,313.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 319 shares of Common Stock at $567.2088 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 41,994.00 | transaction_form_type: 4 | Footnotes: F1, F7
    • Sold 360 shares of Common Stock at $568.159 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 41,634.00 | transaction_form_type: 4 | Footnotes: F1, F8
    • Sold 106 shares of Common Stock at $569.6123 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 41,528.00 | transaction_form_type: 4 | Footnotes: F1, F9
    • Sold 495 shares of Common Stock at $570.2186 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 41,033.00 | transaction_form_type: 4 | Footnotes: F1, F10
    • Sold 520 shares of Common Stock at $571.6638 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1, F11
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-08 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-08 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F12
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-08 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F13
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-08 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F14
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-08 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F15
    • Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
      Date: 2026-05-08 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 24,788.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
    • F10: This transaction was executed in multiple trades at prices ranging from $569.99 to $570.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F11: This transaction was executed in multiple trades at prices ranging from $571.32 to $571.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F12: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
    • F13: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
    • F14: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
    • F15: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
    • F2: This transaction was executed in multiple trades at prices ranging from $561.45 to $562.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F3: This transaction was executed in multiple trades at prices ranging from $562.46 to $563.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F4: This transaction was executed in multiple trades at prices ranging from $563.46 to $564.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F5: This transaction was executed in multiple trades at prices ranging from $564.47 to $565.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F6: This transaction was executed in multiple trades at prices ranging from $565.53 to $566.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F7: This transaction was executed in multiple trades at prices ranging from $566.81 to $567.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F8: This transaction was executed in multiple trades at prices ranging from $567.86 to $568.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F9: This transaction was executed in multiple trades at prices ranging from $568.985 to $569.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.